In hepatocellular carcinoma (HCC) and pancreatic cancer patients, two distinct FoxP3+/− TI Treg subsets exhibiting differential expression patterns of CTLA-4, PD-1, CD25 and CD69 were identified in tumor-infiltrating lymphocyte (TIL) populations. This evidence concerns the gene FOXP3 and pancreatic neoplasm.